Alector (ALEC) Capital Expenditures Growth (3y) (2021 - 2026)
Alector (ALEC) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Alector | 166.99 Mn | -39.52 Mn | - | -53.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.84% |
| Dec 31, 2025 | 26.29% |
| Jun 30, 2025 | -26.55% |
| Mar 31, 2025 | -69.31% |
| Dec 31, 2024 | 37.83% |
| Sep 30, 2024 | -95.98% |
| Jun 30, 2024 | 47.42% |
| Mar 31, 2024 | -5.32% |
| Dec 31, 2023 | 27.26% |
| Sep 30, 2023 | 54.13% |
| Jun 30, 2023 | 14.69% |
| Mar 31, 2023 | -55.94% |
| Sep 30, 2022 | -29.38% |
| Jun 30, 2022 | 28.80% |
| Mar 31, 2022 | -56.29% |
| Dec 31, 2021 | -59.48% |
| Sep 30, 2021 | -31.71% |
| Jun 30, 2021 | 22.65% |
| Mar 31, 2021 | 0.81% |